Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
3.730
+0.270 (7.80%)
At close: Feb 25, 2026, 4:00 PM EST
3.730
0.00 (0.00%)
After-hours: Feb 25, 2026, 4:10 PM EST
Oramed Pharmaceuticals Market Cap
Oramed Pharmaceuticals has a market cap or net worth of $148.46 million as of February 25, 2026. Its market cap has increased by 69.67% in one year.
Market Cap
148.46M
Enterprise Value
5.02M
1-Year Change
69.67%
Ranking
Category
Stock Price
$3.73
Market Cap Chart
Since May 31, 2007, Oramed Pharmaceuticals's market cap has increased from $29.90M to $148.46M, an increase of 396.53%. That is a compound annual growth rate of 8.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 24, 2026 | 137.70M | 21.43% |
| Dec 31, 2025 | 113.40M | 16.19% |
| Dec 31, 2024 | 97.60M | 4.72% |
| Dec 29, 2023 | 93.20M | -80.20% |
| Dec 30, 2022 | 470.60M | -13.48% |
| Dec 31, 2021 | 543.90M | 441.73% |
| Dec 31, 2020 | 100.40M | 12.05% |
| Dec 31, 2019 | 89.60M | 71.98% |
| Dec 31, 2018 | 52.10M | -59.55% |
| Dec 29, 2017 | 128.80M | 58.62% |
| Dec 30, 2016 | 81.20M | -18.15% |
| Dec 31, 2015 | 99.20M | 115.18% |
| Dec 31, 2014 | 46.10M | -62.40% |
| Dec 31, 2013 | 122.60M | 330.18% |
| Dec 31, 2012 | 28.50M | 45.41% |
| Dec 30, 2011 | 19.60M | 11.36% |
| Dec 31, 2010 | 17.60M | -31.52% |
| Dec 31, 2009 | 25.70M | 16.82% |
| Dec 31, 2008 | 22.00M | 83.33% |
| Dec 31, 2007 | 12.00M | -59.87% |
| May 31, 2007 | 29.90M | - |
View and export this data all the way back to 2007. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Whitehawk Therapeutics | 151.05M |
| Black Diamond Therapeutics | 147.00M |
| Corbus Pharmaceuticals Holdings | 143.04M |
| Unicycive Therapeutics | 141.63M |
| Connect Biopharma Holdings | 137.52M |
| Tenaya Therapeutics | 134.41M |
| Alpha Cognition | 130.67M |
| Polaryx Therapeutics | 128.77M |